ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,071.63
0.02%
Dow Jones
38,460.92
-0.11%
US Dollar vs MXN
17.0434
-0.24%
Brent Oil
87.205
-0.02%
Bitcoin
64,062.19
-0.34%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
25/04/202404:23Alliance NewsAlliance NewsAIM WINNERS & LOSERS: Kromek jumps 14% on US government contract
25/04/202404:22Business WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
25/04/202404:20Alliance NewsAlliance NewsIN BRIEF: Schroders gets GBP10 billion rise in assets under managementLSE:SDRSchroders Plc
25/04/202404:20PR Newswire (US)Bitrue Report Uncovers Potential of Decentralized GPU Rental Market to Disrupt Big Tech's Grip on AI Resources
25/04/202404:19GlobeNewswire Inc.Confiance numérique : le firewall souverain Asguard intègre la marketplace de IONOS
25/04/202404:17GlobeNewswire Inc.Man Group PLC : Form 8.3 - Barratt Developments plc
25/04/202404:16Alliance NewsAlliance NewsPersimmon quarterly home completions fall but expects full-year growthLSE:PSNPersimmon Plc
25/04/202404:15Alliance NewsAlliance NewsHikma Pharmaceuticals backs outlook after making strong start to 2024LSE:HIKHikma Pharmaceuticals Plc
25/04/202404:15PR Newswire (US)U.S. Department of Energy Selects LS Power's SWIP-North Project for the Transmission Facilitation Program
25/04/202404:13GlobeNewswire Inc.Man Group PLC : Form 8.3 - Tyman plc
25/04/202404:11PR Newswire (US)Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer
25/04/202404:10GlobeNewswire Inc.Man Group PLC : Form 8.3 - Quanex Building Products Corporation
25/04/202404:10GlobeNewswire Inc.Micron, Biden-Harris Administration, U.S. Senate Majority Leader Schumer Announce $6.1B in CHIPS and Science Act Funding for Historic Planned Investment in Domestic Leading-Edge Memory Manufacturing in Idaho and New YorkNASDAQ:MUMicron Technology Inc
25/04/202404:07PR Newswire (US)PolyU forms global partnership with ZEISS Vision Care to expand impact and accelerate market penetration of patented myopia control technology
25/04/202404:06CointelegraphNigeria puts faith in new crypto-friendly regulatorCOIN:BTCUSDBitcoin
25/04/202404:04Alliance NewsAlliance NewsTOP NEWS: BASF sales and income down but forecast remains unchangedLSE:BFABasf Reg
25/04/202404:03Alliance NewsAlliance NewsWeir Group to meet annual expectations as quarterly output ticks upLSE:WEIRWeir Group Plc
25/04/202404:03PR Newswire (US)Spinergie's digital fleet management platform selected by Seaward Services for remote monitoring and performance optimization
25/04/202404:02PR Newswire (US)CNOOC Limited Achieves Strong Growth in both Net Production and Net Profit in Q1 2024NYSE:CEOCnooc Ltd
25/04/202404:00Alliance NewsAlliance NewsTOP NEWS: WPP holds guidance despite ongoing weakness in Asia and techLSE:WPPWpp Plc
25/04/202404:00GlobeNewswire Inc.Check Point Software Reports 2024 First Quarter Financial ResultsNASDAQ:CHKPCheck Point Software Technologies Inc
25/04/202404:00GlobeNewswire Inc.Orion Group Interim Report January–March 2024BIT:1ORNBVOrion Corporation
25/04/202404:00GlobeNewswire Inc.PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase Ib Clinical Trial Evaluating PEP-010 in Ovarian and Pancreatic Cancers
25/04/202404:00GlobeNewswire Inc.Fraser Institute News Release: Ontario curricula for Grades 1 to 12 lacking in Canadian history
25/04/202404:00PR Newswire (US)TAL Education Group Announces Unaudited Financial Results for the Fourth Fiscal Quarter and the Fiscal Year 2024NYSE:TALTal Education Group
25/04/202403:59Alliance NewsAlliance NewsPureTech touts "momentum" as grants shrivel but annual loss narrowsLSE:PRTCPuretech Health Plc
25/04/202403:58Alliance NewsAlliance NewsRelx confirms annual outlook for revenue and profit growthLSE:RELRelx Plc
25/04/202403:57PR Newswire (US)Chubb Report: Damage During Home Renovations and from Extreme Weather are Top Concerns of U.K. High EarnersNYSE:CBDBA Chubb Limited
25/04/202403:50Alliance NewsAlliance NewsSMALL-CAP WINNERS & LOSERS: LSL Property rises as swings to profit
25/04/202403:49PR Newswire (US)iQIYI Launches Over 300 Titles at 2024 World Conference, Fueling Growth with Diverse Content and Robust IP MonetizationNASDAQ:IQiQiyi Inc

Su Consulta Reciente

COIN
BTCUSD
Bitcoin
NYSE
BAC
Bank of America
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
NYSE
MRK
Merck
NASDAQ
NVDA
NVIDIA
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
USOTC
ADDYY
Adidas (QX)
NASDAQ
GOOGL
Alphabet
NASDAQ
AAPL
Apple
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
NKE
Nike
FX
EURMXN
Euro vs MXN
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados